|
Prepared by FSG Social Impact Advisors and Elliot Marseille and James G. Kahn
The purpose of this study was to investigate the relative
value of the female condom for HIV prevention within
heterosexual relationships in the developing world. In
the last ten years, the world has witnessed both historic
financial commitments to HIV/AIDS and new prevention
options, including biomedical prevention research,
male circumcision, and a dramatic scale-up of voluntary
counseling and testing. At the same time, where HIV
remains at epidemic levels in many countries, there has
been a growing commitment to treatment access alongside
prevention programs. However, portions of populations,
particularly youth and women, remain highly vulnerable to
HIV infection. Accordingly, the global health community
can benefit from a better understanding of how existing
prevention options should be effectively and efficiently
delivered to reduce HIV in the developing world. This
report provides guidance for the global health community
for considering how the female condom fits within the set
of prevention interventions currently available
Download PDF »
|